Raysearch Laboratories
307
SEK
+1.32 %
Less than 1K followers
RAY B
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Ownership
Investor consensus
+1.32%
+17.85%
+22.55%
+42.13%
+47.6%
+119.91%
+358.21%
+271.67%
+450.42%
RaySearch Laboratories operates in the medical technology industry and focuses on the development and manufacture of software for radiation therapy of cancer. The company's products are aimed at healthcare institutions and oncologists. The operations are international and target customers globally. Laboratories was founded in 2000 and is headquartered in Stockholm, Sweden.
Read moreMarket cap
10.52B SEK
Turnover
13.81M SEK
Revenue
1.19B
EBIT %
21.85 %
P/E
51.68
Dividend yield-%
0.98 %
Financial calendar
8/8
2025
Interim report Q2'25
7/11
2025
Interim report Q3'25
All
Press releases
ShowingAll content types
RaySearch Laboratories: Bulletin from the Annual General Meeting 2025
Finansinspektionen: Flaggningsmeddelande i RaySearch Laboratories AB (publ)
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools